[go: up one dir, main page]

MXPA02006030A - Lipopeptidos como agentes antibacterianos. - Google Patents

Lipopeptidos como agentes antibacterianos.

Info

Publication number
MXPA02006030A
MXPA02006030A MXPA02006030A MXPA02006030A MXPA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A MX PA02006030 A MXPA02006030 A MX PA02006030A
Authority
MX
Mexico
Prior art keywords
compounds
lipopeptides
antibacterial agents
relates
producing
Prior art date
Application number
MXPA02006030A
Other languages
English (en)
Inventor
Michael Morytko
Original Assignee
Cubist Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cubist Pharm Inc filed Critical Cubist Pharm Inc
Publication of MXPA02006030A publication Critical patent/MXPA02006030A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invencion se relaciona con compuestos lipopeptidicos novedosos. La invencion tambien se relaciona con composiciones farmaceuticas de estos compuestos y los metodos para utilizar estos compuestos como compuestos antibacterianos. La invencion tambien se relaciona con los metodos para producir estos compuestos lipopeptidicos novedosos y los intermediarios utilizados para producir estos compuestos.
MXPA02006030A 1999-12-15 2000-12-15 Lipopeptidos como agentes antibacterianos. MXPA02006030A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17094699P 1999-12-15 1999-12-15
US20822200P 2000-05-30 2000-05-30
PCT/US2000/034205 WO2001044274A1 (en) 1999-12-15 2000-12-15 Lipopeptides as antibacterial agents

Publications (1)

Publication Number Publication Date
MXPA02006030A true MXPA02006030A (es) 2004-08-23

Family

ID=26866577

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006030A MXPA02006030A (es) 1999-12-15 2000-12-15 Lipopeptidos como agentes antibacterianos.

Country Status (12)

Country Link
US (3) US7408025B2 (es)
EP (1) EP1246838A1 (es)
JP (1) JP2003517480A (es)
KR (1) KR20020063228A (es)
CN (1) CN1423656A (es)
AU (1) AU784812B2 (es)
BR (1) BR0016467A (es)
CA (1) CA2394350A1 (es)
IL (1) IL150225A0 (es)
MX (1) MXPA02006030A (es)
NO (1) NO20022887L (es)
WO (1) WO2001044274A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
CA2432096A1 (en) 2000-12-18 2002-08-01 Cubist Pharmaceuticals, Inc. Methods for preparing purified lipopeptides
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
ATE430160T1 (de) * 2001-08-06 2009-05-15 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
US6767718B2 (en) 2002-05-10 2004-07-27 Biosource Pharm, Inc. Lipodepsipeptide antibiotics and methods of preparation
WO2003103699A1 (en) 2002-06-06 2003-12-18 Vicuron Pharmaceuticals Inc. Use of ramoplanin to treat diseases associated with the use of antibiotics
US7521560B2 (en) 2004-06-29 2009-04-21 Rigel Pharmaceuticals, Inc. 2-substituted quinoline compounds and their uses
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
FR2874922A1 (fr) * 2004-07-30 2006-03-10 Palumed Sa Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
JP2008508243A (ja) * 2004-07-30 2008-03-21 パルメド・ソシエテ・アノニム アミノキノリンをｑとし、抗生物質残基をａとする混成分子ｑａ、その合成及び抗菌剤としての使用
CA2587848A1 (en) * 2004-11-12 2006-10-19 Cubist Pharmaceuticals, Inc. Antiinfective lipopeptides
NZ563271A (en) 2005-04-29 2009-12-24 Cubist Pharm Inc Therapeutic compositions
US7964729B2 (en) 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
US8440835B2 (en) 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
NZ594019A (en) * 2008-12-22 2013-08-30 Cubist Pharm Inc Novel antibacterial agents for the treatment of gram positive infections
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
WO2011025546A1 (en) 2009-08-31 2011-03-03 Massachusetts Institute Of Technology 1, 2, 3-triazole containing protein kinase sensors
LT2504353T (lt) 2009-11-23 2018-09-25 Cubist Pharmaceuticals Llc Lipopeptidų kompozicijos ir susiję būdai
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
CA2806362A1 (en) * 2010-07-23 2012-01-26 Activbiotics Pharma, Llc Administration of rifalazil to immunocompromised patients
WO2012027495A1 (en) 2010-08-27 2012-03-01 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
US20120317234A1 (en) * 2011-06-09 2012-12-13 International Business Machines Corporation Managing data access in mobile devices
WO2013059610A1 (en) 2011-10-20 2013-04-25 Trius Therapeutics, Inc. Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
US9165332B2 (en) * 2012-01-27 2015-10-20 Microsoft Technology Licensing, Llc Application licensing using multiple forms of licensing
US9348608B2 (en) * 2013-04-24 2016-05-24 QRC, Inc. System and method for registering application and application transforms on a radiofrequency digitization and collection device
HK1223361A1 (zh) * 2013-05-24 2017-07-28 Société des Produits Nestlé S.A. 用於预测肠易激综合征诊断的途径特异性测定
CN104322562B (zh) * 2014-09-16 2017-04-26 南京农业大学 一种脂肽‑高岭土复合生防制剂及其制备方法和应用
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
US10647746B2 (en) * 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
CN111542533A (zh) * 2017-08-01 2020-08-14 新加坡科技研究局 抗微生物肽模拟物
AU2021233893A1 (en) 2020-03-12 2022-08-25 Baxter Healthcare Sa Daptomycin formulations containing a combination of sorbitol and mannitol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524135A (en) * 1982-05-21 1985-06-18 Eli Lilly And Company A-21978C cyclic peptides
USRE32311E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
USRE32310E (en) 1982-05-21 1986-12-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4399067A (en) * 1982-05-21 1983-08-16 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
US4537717A (en) * 1982-05-21 1985-08-27 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
IL68700A0 (en) * 1982-05-21 1983-09-30 Lilly Co Eli Improvements relating to a-21978c cyclic peptide derivatives and their production
US4482487A (en) * 1982-05-21 1984-11-13 Eli Lilly And Company A-21978C cyclic peptides
US4396543A (en) * 1982-05-21 1983-08-02 Eli Lilly And Company Derivatives of A-21978C cyclic peptides
ATE67788T1 (de) * 1984-10-09 1991-10-15 Lilly Co Eli Herstellung von derivaten von a-21978c.
CA1315229C (en) 1987-06-10 1993-03-30 Patrick J. Baker Chromatographic purification process
ATE140728T1 (de) * 1990-06-07 1996-08-15 Lilly Co Eli Lipopeptid deacylase
DE4411025A1 (de) 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
ES2327981T3 (es) 1996-03-08 2009-11-05 Astellas Pharma Inc. Procedimiento para la desacilacion de lipopeptidos ciclicos.
DE19807972A1 (de) 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
JP4990456B2 (ja) * 1999-12-15 2012-08-01 キュービスト ファーマシューティカルズ， インコーポレイテッド 抗菌剤としてのダプトマイシンアナログ
CN1423655A (zh) * 1999-12-15 2003-06-11 卡比斯特制药公司 作为抗菌剂的新颖的脂肽

Also Published As

Publication number Publication date
US20040067878A1 (en) 2004-04-08
IL150225A0 (en) 2002-12-01
JP2003517480A (ja) 2003-05-27
NO20022887L (no) 2002-08-12
CN1423656A (zh) 2003-06-11
AU784812B2 (en) 2006-06-29
CA2394350A1 (en) 2001-06-21
AU3635701A (en) 2001-06-25
US7408025B2 (en) 2008-08-05
US20080287347A1 (en) 2008-11-20
NO20022887D0 (no) 2002-06-17
BR0016467A (pt) 2002-08-27
KR20020063228A (ko) 2002-08-01
WO2001044274A1 (en) 2001-06-21
EP1246838A1 (en) 2002-10-09
US20090011977A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
MXPA02006028A (es) Lipopeptidos novedosos como agentes antibacterianos.
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
AU2002353775A1 (en) Lipopeptide stereoisomers, methods for preparing same, and useful intermediates
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
PL358281A1 (en) Novel compounds
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
AU3227700A (en) Skin sanitizing compositions
PL360254A1 (en) Pharmaceutical compositions
DE60033649D1 (de) Verbindungen und therapeutische methoden
SE9901077D0 (sv) Novel use
DE50113345D1 (de) Arginin-mimetika als faktor xa-inhibitoren
YU79202A (sh) Peptid koji modulira trombopoetinski receptor
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
IL150979A0 (en) 9-alkylamino-1-nitroacridine derivatives
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
DE60212101D1 (de) Alanin-2,6-dialkoxyphenylesterderivate als hypnotika
MXPA05003633A (es) 2"-oxo-voruscharina y derivados de la misma.
SE9902147L (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal